Data Foundry

Drug recalls 2026

IMAAVY — Class II drug recall D-0016-2027

Ongoing recall by J&J INNOVATIVE MEDICINE, reported 2026-10-14, distributed in OH. Presence of particulate matter.

Recall numberD-0016-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmJ&J INNOVATIVE MEDICINE, Malvern, PA, United States
Recall initiated2026-09-23
Classified2026-10-08
Reported by FDA2026-10-14
DistributedOH
Quantity49 vials
Reason classesspecification failure
NDC57894-0800, 57894-0800-01, 57894-0801, 57894-0801-01
Lot numbersJNYJ1208
Expiration dates2027-10-30

Product

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01

Reason for recall

Presence of particulate matter.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0016-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.